Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
Indian J Public Health
;
2006 Jan-Mar; 50(1): 43-4
Article
in English
| IMSEAR
| ID: sea-109820
ABSTRACT
Along with hepatitis B virus (HBV) and human immunodeficiency virus (HIV), Hepatitis C virus (HCV) is emerging as a major transfusion hazard. 22 cases of haemophilia (A 19, B 3) and 20 cases of thalassaemia (2 16, E(2) 4) constituted the study group. Patients tested for anti HCV (using third generation ELISA), HBsAg and antibodies to HIV I and II. Prevalence of anti HCV was 54.5% in haemophilics and 5% in thalassaemics. HBsAg was detected in 9.09% haemophilics and 5% thalassaemics. No anti HIV was detected in this cohort. Anti HCV seropositivity in haemophilics has increased compare to previous studies.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Thalassemia
/
Blood Transfusion
/
Humans
/
Seroepidemiologic Studies
/
Child
/
Child, Preschool
/
Prevalence
/
Adolescent
/
HIV
/
Hepatitis C
Type of study:
Etiology study
/
Prevalence study
/
Risk factors
Language:
English
Journal:
Indian J Public Health
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS